MarketInOut Stock Screener Log In | Sign Up

Ginkgo Bioworks Holdings Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Ginkgo Bioworks Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization885.52 mln
Float49.11 mln
Earnings Date11/16/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-3.19
Reliable

1-Year Forecast

8.00
Downside risk

Relative Strength

94 / 100
Top performer

Debt / Equity

0.96
Moderate leverage

Pre-Tax Margin

-264%
Severely loss-making

Business Description

Founded in 2008 and based in Boston, Ginkgo Bioworks helps companies across industries design and build living cells for practical use, from developing new drugs and agricultural solutions to improving food ingredients and industrial processes. Its platform combines automation, artificial intelligence, and genomic tools to make cell engineering faster and more accessible for research and commercial applications. The company also operates a biosecurity division that monitors environmental and biological threats through sensor networks and data analytics.

Key Fundamentals

EPS-5.06
ROE-61.95
RPS2.26
ROIC-41.17
ROA-28.34
EBITDA, mln-243
EV / EBITDA-3.45
EV / EBIT-2.84
Revenue, mln112
EV / Revenue7.49

Quote Details

Last 11.21
Change -1.53 (-12.01%)
Open 12.12
Volume 2,726,848
Turnover 30,567,966
Average Volume 3,450,268

Financial Ratios

Pre-Tax Profit Margin-264
Leverage Ratio2.36
Current Ratio4.57
Price / Book1.63
Price / Tangible Book1.82
Debt / Equity0.96
Price / Sales5.76

Financial Strength

Altman Z-Score-8.76
Piotroski F-Score 1 / 9
Beneish M-Score-3.19
1-Year Target Price8.00
Short Ratio2.40
Short % of Float15.46

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 12.21% 98 / 100   
1 Month -10.32% 13 / 100   
2 Months 50.47% 99 / 100   
6 Months 15.57% 88 / 100   
1 Year -8.04% 22 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog